0000919574-26-006827.txt : 20261009 0000919574-26-006827.hdr.sgml : 20261009 20261009155314 ACCESSION NUMBER: 0000919574-26-006827 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20261009 DATE AS OF CHANGE: 20261009 EFFECTIVENESS DATE: 20261009 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sofinnova BioEquities Enhanced Master Fund, LP CENTRAL INDEX KEY: 0001949475 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-461670 FILM NUMBER: 261452772 BUSINESS ADDRESS: STREET 1: 3000 SAND HILL ROAD STREET 2: BUILDING 3, SUITE 150 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-681-8482 MAIL ADDRESS: STREET 1: 3000 SAND HILL ROAD STREET 2: BUILDING 3, SUITE 150 CITY: MENLO PARK STATE: CA ZIP: 94025 D/A 1 primary_doc.xml X0708 D/A LIVE 0001949475 Sofinnova BioEquities Enhanced Master Fund, LP 3000 SAND HILL ROAD BUILDING 3, SUITE 150 MENLO PARK CA CALIFORNIA 94025 650-681-8482 DELAWARE None None Limited Partnership true 2022 -- Sofinnova BioEquities GP LLC 3000 Sand Hill Road BUILDING 3, SUITE 150 Menlo Park CA CALIFORNIA 94025 Executive Officer Promoter General Partner -- Sofinnova Investments, Inc. 3000 Sand Hill Road BUILDING 3, SUITE 150 Menlo Park CA CALIFORNIA 94025 Executive Officer Promoter Investment Manager Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.7 true 0000919574-25-006040 2022-10-03 true true true false 0 Indefinite 87225567 Indefinite false 26 0 true 0 true 0 true The Investment Manager receives customary management fees. false Sofinnova BioEquities Enhanced Master Fund, LP /s/ Jim Brody Jim Brody Chief Compliance Officer 2026-10-09